World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Groups
How India could get the Trade Deal with the US by buying oil from US and Saudis/UAE and allowing imports of non grain and non dairy agricultural products
08/28/2025
US sanctioned India with 50% tariff for buying Russian oil saying it finances RUssia's war against Ukraine and daily deadly missile strikes. ein dollar terms are now insignificant at $2-the 3 billion. In fact India is already shifting to getting more of its imports from the Middle East. India could also import additional oil from the US and make changes to import non grain and non dairy agricultural products from the US in large volumes such as almonds, walnuts, pistachios, blueberries, cherries that it's upper middle class population of 250 million could benefit from the nutritional benefits. US in its fight against the pharmaceutical companies high pricing could change laws to bring in Indian pharmaceutical products at 10-15% price above Indian prices set by the government to meet needs of its large population. In pharma product pricing India leads the whole world and this benefit would lower the cost of living in the US tremendously. Both sides would benefit in a WIn-WIn relationship in trade- THIS IS ACHIEVABLE FOR THE INTERESTS OF AMERICANS AND INDIANS. IT ONLY REQUIRES VISION OF BOTH SIDES.
Grouped Articles
India's benefit from Russian oil imports exaggerated; actual gain at just $2.5 bn
The Economic Times 08/28/2025
Opinion | America’s Fearsome Farm Lobby Has Nothing on India’s
The Wall Street Journal 08/27/2025
Failure to control overbilling by pharmaceutical companies, medical equipment and device makers in the health reform bill.
12/10/2009
Only $10 million annual increase to control fraud has been allocated in the bill. Its not likely to do much to control the overbilling and may be one more reason the health care reform bill will be a failure in controlling costs. Pricing of pharmaceutical products and healthcare services as the major unsolved problem in the U.S.
Grouped Articles
New York Times 12/21/2013
BusinessWeek 12/10/2009
How the Senate bill would contain the cost of health care : The New Yorker
New Yorker 01/04/2010
In Battle Over Health Law, Math Cuts Both Ways
New York Times 01/07/2011
House Approves Health Law Repeal
Wall Street Journal 01/20/2011
A grim diagnosis for our ailing U.S. health care system - The Washington Post
Washington Post 11/28/2011
Indian pharmaceutical companies and patent challenges.
07/07/2009
Grouped Articles
India Orders Bayer to License Patented Cancer Drug
New York Times 03/12/2012
India Rejects Novartis Patent Claim
Wall Street Journal 07/07/2009
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
India-E.U. trade pact could boost AIDS treatment costs, health workers say - The Washington Post
Washington Post 02/11/2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Glaxo partnerships with other pharmaceutical companies.
07/07/2008
Partnersuip wit Dr. Reddy's in India and South Africa's Aspen Pharmacare.
Grouped Articles
Glaxo Seeks Guidance From Health Systems
Wall Street Journal 07/07/2008
Glaxo and Pfizer Join Forces to Develop and Market H.I.V. Drugs
New York Times 04/17/2009
Glaxo Seals Marketing Pact With Dr. Reddy's
Wall Street Journal 06/16/2009
The Four Ps of Global Business Expansion
Wall Street Journal 11/12/2010
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Wall Street Journal 05/11/2012
Pharmaceutical company pricing in the U.S. and Europe
11/09/2007
The pricing of pharmaceutical products and healthcare services in the U.S. and Europe.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
Democrats Say No to Cost Cap for Drug Makers
New York Times 08/07/2009
Economist 08/27/2009
Large Price Jumps Reported for Small but Vital Drugs
New York Times 01/11/2010
Japan's pharmaceutical companies.
01/19/2007
The pharmaceutical industry in Japan.
Grouped Articles
Big Drug Merger Shapes Up in Japan
Wall Street Journal 01/19/2007
Japanese Drug Company Bids for U.S. Biotech Firm
New York Times 04/11/2008
Wall Street Journal 11/21/2008
Wall Street Journal 03/02/2009
Japan Drug Makers' Growth Slows
Wall Street Journal 08/03/2009
Drug Firm From Japan Buys Maker of Lunesta
New York Times 09/04/2009
Pharmaceutical companies fighting generics.
10/22/2006
Pharmaceutical compaies are trying to make it harder for pharmacists to substitute generics.
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Industry Fights Switch To Generics for Epilepsy
Wall Street Journal 07/13/2007
Wall Street Journal 02/06/2008
TriCor Case May Illuminate Patent Limits
Wall Street Journal 06/02/2008
How a Drug Maker Tries to Outwit Generics
Wall Street Journal 11/17/2008
Ending the Silence of Generic Drugmakers
BusinessWeek 06/24/2010
Indian pharmaceutical companies and export markets.
02/09/2006
Grouped Articles
Indian Drugmakers Target Niche Markets
Wall Street Journal 04/19/2016
In Trade Deal, a Shift on Generics
Wall Street Journal 05/17/2007
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
BusinessWeek 09/04/2008
Pharmaceutical company advertising and questions raised.
08/03/2005
Grouped Articles
Drug Makers to Police Consumer Campaigns
New York Times 08/03/2005
Drug Makers, Facing Critics, Will Stop Some Ads
Wall Street Journal 12/11/2008
Drug Firms' Spending on Consumer Ads Fell 8% in '08, a Rare Marketing Pullback
Wall Street Journal 04/16/2009
Drug Makers to Press for Guidance on Web Marketing
Wall Street Journal 11/12/2009
Boehringer.
06/16/2010
German pharmaceutical company Boehringer.
Grouped Articles
Maker Plays Up Sexual Disorder, With a Pill in Waiting
New York Times 06/16/10
Money from pharmaceutical companies to doctors.
12/31/2008
Grouped Articles
No Mug? Drug Makers Cut Out Goodies for Doctors
New York Times 12/31/08
European pharmaceutical companies.
12/06/2007
Grouped Articles
Big Pharma Faces Grim Prognosis
Wall Street Journal 12/06/07
Wall Street Journal 06/27/08
Europe Accuses Drug Makers of Padding Health Care Costs
New York Times 11/29/08
EU Opens an Antitrust Probe Of Servier, Generic Drug Makers
Wall Street Journal 07/09/09
Drug Firms Feel Pinch From Europe
Wall Street Journal 07/29/10
Austerity in Europe Puts Pressure on Drug Companies
New York Times 02/23/12
China's pharmaceutical companies and export markets.
10/09/2007
Grouped Articles
U.S. Opens the Door to Chinese Pills
Wall Street Journal 10/09/07
A Prescription for Chinese Health-Care Stocks
Wall Street Journal 06/28/10
BusinessWeek 11/10/11
European pharmaceutical companies and marketing practices.
10/25/2006
Grouped Articles
Big Pharma Faces Grim Prognosis
Wall Street Journal 12/06/07
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/06
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/12
Mergers among European pharmaceutical companies.
09/26/2006
Grouped Articles
Economist 09/28/06
European Midsize Drug Makers Become Possible Takeover Targets - WSJ.com
Wall Street Journal 09/26/06
Europe Drug Firms Join Slimming Trend - WSJ.com
Wall Street Journal 01/05/07
Europe Accuses Drug Makers of Padding Health Care Costs
New York Times 11/29/08
Acquisitions by Indian pharmaceutical companies.
02/09/2006
Grouped Articles
Indian Drugmakers Target Niche Markets
Wall Street Journal 04/19/16
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/06
Indian Companies Hit Their Stride
BusinessWeek 09/17/07
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/12
No Miracle Cure From Pharmaceutical Mergers
Wall Street Journal 04/07/12
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
